74476-32-7

Usage

Molecular structure

1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[(4-methylphenyl)sulfonyl]oxy]-7-oxo-, phenylmethyl ester is a complex organic compound that features a bicyclic ring system, which includes a seven-membered azabicycle and a five-membered ring. It also contains a carboxylic acid functional group, a sulfonyl group, and a phenylmethyl ester group.

Bicyclic ring system

The compound has a unique bicyclic ring system, which consists of a seven-membered azabicycle (with one nitrogen atom) and a five-membered ring. This structure contributes to the compound's stability and may have implications for its potential applications in the pharmaceutical industry.

Carboxylic acid functional group

The presence of a carboxylic acid functional group (-COOH) in the compound allows it to form hydrogen bonds and participate in various chemical reactions. This functional group is commonly found in drug molecules and may contribute to the compound's potential pharmaceutical applications.

Sulfonyl group

The sulfonyl group (-SO2-) in the compound suggests that it may have some level of reactivity. This group can be involved in various chemical reactions, such as nucleophilic substitution and elimination reactions. The presence of the sulfonyl group may make 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[(4-methylphenyl)sulfonyl]oxy]-7-oxo-, phenylmethyl ester a useful reagent in certain chemical processes.

Potential pharmaceutical applications

Due to its complex structure and the presence of functional groups commonly found in drug molecules, 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[(4-methylphenyl)sulfonyl]oxy]-7-oxo-, phenylmethyl ester may have potential applications in the pharmaceutical industry. Further research would be necessary to fully understand its properties and potential uses.

Reactivity

The presence of the sulfonyl group in the compound suggests that it may have some level of reactivity, which could make it a useful reagent for certain chemical reactions. Further investigation would be needed to determine the specific reactions in which 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[(4-methylphenyl)sulfonyl]oxy]-7-oxo-, phenylmethyl ester could be involved.

Upstream product

• 4124-41-8 p-toluenesulfonylanhydride 
• 74476-30-5 (2S,5S)-3,7-Dioxo-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid benzyl ester 
• 74476-30-5 benzyl 1-azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylate 
• 67501-91-1 N-(t-butyldimethylsilyl)-4-(2-acetoxyethyl)-azetidin-2-one 
• 67501-92-2 N-(t-butyldimethylsilyl)-4-(2-hydroxyethyl)-azetidin-2-one 
• 67501-93-3 (4RS)-1-(tert-butyl-dimethylsilyl)-4-(2-oxoethyl)-2-oxoazetidine 
• 64066-60-0 4-(2-acetoxyethyl)-2-azetidinone 
• 74476-29-2 4-(3-benzyloxycarbonyl-3-diazo-2-oxopropyl)-azetidin-2-one 
• 74476-28-1 benzyl 3-oxo-4-[(2RS)-4-oxoazetidin-2-yl]butanoate 
• 81957-87-1 N-(t-butyldimethylsilyl)-4-(3-benzyloxycarbonyl-2-hydroxypropyl)-azetidin-2-one 
• 74476-27-0 benzyl 4-[(2RS)-1-(tert-butyl-dimethylsilyl)-4-oxoazetidin-2-yl]-3-oxobutanoate 
• 140-11-4 Benzyl acetate 

Downstream Products

• 74476-33-8 3-[2-(4-Nitro-benzyloxycarbonylamino)-ethylsulfanyl]-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid benzyl ester 
• 101989-51-9 benzyl 2-(2-acetoxyaziridin-1-yl)-carbapen-2-em-3-carboxylate 
• 101989-41-7 7-Oxo-3-(3a,5,6,6a-tetrahydro-furo[2,3-d][1,2,3]triazol-3-yl)-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid benzyl ester 
• 101989-45-1 benzyl 2-(4-[2-hydroxyethyl]-1,2,3-triazol-1-yl)-carbapen-2-em-3-carboxylate 
• 101989-47-3 3-[4-(3-Hydroxy-propyl)-[1,2,3]triazol-1-yl]-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid benzyl ester 
• 101989-43-9 7-Oxo-3-(5,6,7,7a-tetrahydro-3aH-pyrano[2,3-d][1,2,3]triazol-3-yl)-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid benzyl ester 
• 101989-38-2 benzyl 2-azido-carbapen-2-em-3-carboxylate 

Relevant academic research and scientific papers

6- and 6,6-disubstituted-3-substituted-1-azabicyclo(3.2.0)hept-2-en-7-one-2-carboxylic acids

Disclosed are 6- and 6,6-disubstituted-3-substituted-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acids (I): STR1 wherein R1 and R2 are, inter alia, independently selected from the group consisting of hydrogen (both are not hydrog

Process for preparing 3-substituted-6-substituted-7-oxo-1-azabicycl(3.2.0)-hept-2-ene-2-carboxylic acid

Disclosed is a process for preparing 3-substituted-thio-6-(1'-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acids (I) STR1 wherein X is a leaving group such as chloro, bromo, tosyl, mesyl or the like; and R8 is, inter alia, sel

Process for preparing 3-substituted-6-substituted-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

Disclosed is a process for preparing 3- and 6-substituted-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acids: STR1 wherein: X is a leaving group such as chloro, bromo, tosyl, mesyl or the like; and R6, R7 and R8 are, i

6- And 6,6-disubstituted-3-substituted amino-1-azabicyclo-[3.2.0]hept-2-en-7-one-2-carboxylic acid

Disclosed are 6- and 6,6-disubstituted-3-substituted amino-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acids (I): STR1 wherein R1 and R2 are, inter alia, independently selected from the group consisting of hydrogen, substituted a

6-(1'-Hydroxyethyl)-3-substituted amino-1-azabicyclo-?3.2.0!hept-2-en-7-one-2-carboxylic acid

Disclosed are 6-(1'-hydroxyethyl)-3-substituted amino-1-azabicyclo?3.2.0!hept-2-en-7-one-2-carboxylic acids (I): STR1 wherein R' and R" are independently selected from H, substituted and unsubstituted alkyl and aralkyl groups, or together form a substitut

3-Substituted-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid

Disclosed are 3-substituted-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acids (I): STR1 wherein R is, inter alia, acyl, alkyl, and aralkyl. Such compounds and their pharmaceutically acceptable salt, ester and amide derivatives are useful as antibiotic

3-Halo-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid

Disclosed is 3-halo-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid (I): STR1 Such compounds, wherein X is halo, and their pharmaceutically acceptable salt, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the p

6-(1-Hydroxyethyl)-3-substituted-1-azabicyclo(3.2.0)-hept-2-en-7-one-2-carboxylic acid

Disclosed are 6-(1'-hydroxyethyl)-3-substituted-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acids(I): STR1 wherein X is halo, oxygen (the 2-3 bond is saturated and the species I exists as the carboxylate salt or ester), or --OR wherein R is, inter ali

1-Azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylic acid

Disclosed are the pharmaceutically acceptable salt and ester forms of 1-azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylic acid (I): STR1 Such compounds are useful as antibiotics. Also disclosed are processes for the preparation of such compounds, pharmaceuti

A novel synthesis of the carbapen-2-em ring system

A new synthesis of the carbapenem ring system, as found in thienamycin and related natural products, has been developed. The key step involves a highly efficient carbene insertion reaction which produces the bicyclic ring system by forming the N3 bond.